drugset / Trial / NCT00553488

Feasibility Study of the Effect of Intra-Dermal Insulin Injection on Blood Glucose Levels After Eating

NCT00553488

Phase 2 Completed 30 enrolled Becton, Dickinson and Company
RandomizedCrossoverOpen-labelTreatment

Summary

This study is to determine the effect of intra-dermal (ID) administration of regular and of rapid-acting insulin, before eating, on blood glucose levels for several hours after a standard meal (a mixed, liquid meal). Insulin will also be given normally, subcutaneously, for control or comparison purposes. The hypothesis or expectation is that ID insulin will work more quickly and control blood glucose levels better than SC injection.

Timeline

Start
2007-09
Primary completion
2007-12
Completion
2008-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Insulin Protein / enzyme biologic 0.125 iu/kg Subcutaneous
Subject Insulin Lispro Protein / enzyme biologic 0.125 iu/kg Subcutaneous